Since CDR1as has been previously shown to modulate EGFR and KLF4 in breast cancer development, and these genes play importat roles also in the skin, it will be interesting to assess its potential tumor suppressive effect in the context of cSCC. The gene discussed is EGFR; the disease is neoplasm.